Multidrug-resistant tuberculosis – Authors' reply

Linezolid for multidrug-resistant tuberculosis - authors' reply.

In their Comment in The Lancet Infectious Diseases, Kwok-Chiu Chang and colleagues concluded that expansion of access to linezolid for complicated cases of drug-resistant tuberculosis risks the loss of a potentially useful drug and could promote the emergence and spread of drug-resistant tuberculosis in the community. The rationale behind this idea seems to be the scarcity of controlled clinica...

Multidrug-Resistant TB in the Philippines: Authors' Reply

Bill Anderson Escobar et al.’s discussion of medically unexplained physical symptoms is useful, and could trigger a renewal of how the medical profession works [1]. We are in transition at the present, and what we have been trained for is less and less relevant. This disjunction between our training and practise has given rise to a generation of unhappy doctors. The traditional “doctor” dealt w...

The Authors’ Reply

The Authors’ Reply

The Authors’ Reply